SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000030
Filing Date
2021-11-05
Accepted
2021-11-05 16:05:50
Documents
49
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q enzn-20210930x10q.htm   iXBRL 10-Q 731088
2 EX-31.1 enzn-20210930xex31d1.htm EX-31.1 13927
3 EX-32.1 enzn-20210930xex32d1.htm EX-32.1 6769
  Complete submission text file 0001410578-21-000030.txt   2836567

Data Files

Seq Description Document Type Size
4 EX-101.SCH enzn-20210930.xsd EX-101.SCH 30512
5 EX-101.CAL enzn-20210930_cal.xml EX-101.CAL 16832
6 EX-101.DEF enzn-20210930_def.xml EX-101.DEF 86197
7 EX-101.LAB enzn-20210930_lab.xml EX-101.LAB 178337
8 EX-101.PRE enzn-20210930_pre.xml EX-101.PRE 157058
9 EXTRACTED XBRL INSTANCE DOCUMENT enzn-20210930x10q_htm.xml XML 324111
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 211384512
SIC: 2836 Biological Products, (No Diagnostic Substances)